| Mar 2, 2026 |
Mar 4, 2026 |
Krainer Adrian R.
|
Director |
Sell |
41.3
|
-7,229
|
-2.23%
|
✓
|
$286.7K |
| Feb 17, 2026 |
Feb 19, 2026 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 17, 2026 |
Feb 19, 2026 |
SMITH IAN F
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 17, 2026 |
Feb 19, 2026 |
Leggett Thomas
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 17, 2026 |
Feb 19, 2026 |
Hoitt Jason
|
Chief Patient Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 17, 2026 |
Feb 19, 2026 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 31, 2025 |
Jan 5, 2026 |
LEVIN ARTHUR A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 8, 2025 |
Dec 10, 2025 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
10.0
|
-3,978
|
-25.16%
|
✓
|
$128.4K |
| Dec 8, 2025 |
Dec 10, 2025 |
Kaye Edward M. MD
|
Director |
Sell |
12.5
|
-13,430
|
-21.47%
|
✓
|
$433.4K |
| Dec 3, 2025 |
Dec 5, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
15.0
|
-5,358
|
-21.30%
|
✓
|
$167.1K |
| Dec 3, 2025 |
Dec 5, 2025 |
Kaye Edward M. MD
|
Director |
Sell |
17.5
|
-15,001
|
-19.34%
|
✓
|
$467K |
| Dec 3, 2025 |
Dec 5, 2025 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
7.5
|
-9,803
|
-38.28%
|
✓
|
$306.3K |
| Dec 1, 2025 |
Dec 3, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
42.5
|
-4,020
|
-20.96%
|
✗
|
$121.5K |
| Dec 1, 2024 |
Dec 3, 2025 |
Kaye Edward M. MD
|
Director |
Sell |
42.5
|
-2,136
|
-4.00%
|
✗
|
$64.5K |
| Dec 1, 2025 |
Dec 3, 2025 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
42.5
|
-4,576
|
-18.92%
|
✗
|
$138.3K |
| Nov 24, 2025 |
Nov 26, 2025 |
Krainer Adrian R.
|
Director |
Sell |
20.0
|
-40,472
|
-11.11%
|
✓
|
$1.2M |
| Nov 14, 2025 |
Nov 18, 2025 |
Krainer Adrian R.
|
Director |
Sell |
20.0
|
-40,472
|
-10.00%
|
✓
|
$1.1M |
| Nov 3, 2025 |
Nov 5, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-5,931
|
-45.19%
|
✓
|
$152.6K |
| Oct 8, 2025 |
Oct 14, 2025 |
SMITH IAN F
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 8, 2025 |
Oct 10, 2025 |
Kaye Edward M. MD
|
Director |
Sell |
7.5
|
-25,000
|
-33.73%
|
✓
|
$750K |
| Oct 3, 2025 |
Oct 7, 2025 |
Kaye Edward M. MD
|
Director |
Sell |
5.0
|
-42,461
|
-46.36%
|
✓
|
$1.1M |
| Oct 3, 2025 |
Oct 7, 2025 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
7.5
|
-10,000
|
-45.81%
|
✓
|
$250.7K |
| Oct 1, 2025 |
Oct 3, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-5,343
|
-28.93%
|
✓
|
$126.3K |
| Sep 30, 2025 |
Oct 1, 2025 |
LEVIN ARTHUR A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 4, 2025 |
Sep 5, 2025 |
Kaye Edward M. MD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 2, 2025 |
Sep 3, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
15.0
|
-5,501
|
-22.95%
|
✓
|
$109.3K |
| Aug 29, 2025 |
Sep 3, 2025 |
Kaye Edward M. MD
|
Director |
Sell |
5.0
|
-61,885
|
-40.32%
|
✓
|
$1.2M |
| Aug 29, 2025 |
Sep 3, 2025 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
7.5
|
-22,117
|
-29.07%
|
✓
|
$444.8K |
| Aug 18, 2025 |
Aug 20, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
42.5
|
-2,805
|
-10.48%
|
✗
|
$51.2K |
| Aug 18, 2025 |
Aug 20, 2025 |
Kaye Edward M. MD
|
Director |
Sell |
42.5
|
-12,126
|
-7.32%
|
✗
|
$221.2K |
| Aug 18, 2025 |
Aug 20, 2025 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
46.3
|
-1,683
|
-6.57%
|
✗
|
$30.7K |
| Aug 14, 2025 |
Aug 18, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 14, 2025 |
Aug 18, 2025 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 14, 2025 |
Aug 18, 2025 |
Kaye Edward M. MD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 13, 2025 |
Aug 15, 2025 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
10.0
|
-13,712
|
-41.12%
|
✓
|
$205.7K |
| Aug 1, 2025 |
Aug 5, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
15.0
|
-4,504
|
-21.17%
|
✓
|
$57.7K |
| Jul 1, 2025 |
Jul 2, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
20.0
|
-4,503
|
-17.47%
|
✓
|
$52.4K |
| Jun 30, 2025 |
Jul 2, 2025 |
LEVIN ARTHUR A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 23, 2025 |
Hoitt Jason
|
Chief Patient Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
Skorpios Trust
|
10% Owner |
Sell |
15.0
|
-3,000,000
|
-43.44%
|
✗
|
$30.6M |
| Jun 3, 2025 |
Jun 4, 2025 |
Smith Julie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 4, 2025 |
LEVIN ARTHUR A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 4, 2025 |
Menzel Garry E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 4, 2025 |
Krainer Adrian R.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 4, 2025 |
Harrison Seth Loring
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 4, 2025 |
Burstein Jennifer
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 2, 2025 |
Jun 4, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
15.0
|
-8,216
|
-24.17%
|
✓
|
$82.3K |
| May 1, 2025 |
May 5, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
7.5
|
-26,631
|
-43.92%
|
✓
|
$267K |
| Mar 31, 2025 |
Apr 2, 2025 |
LEVIN ARTHUR A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 20, 2025 |
Mar 20, 2025 |
SMITH IAN F
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 20, 2025 |
Mar 20, 2025 |
TZIANABOS ARTHUR
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 20, 2025 |
Mar 20, 2025 |
Leggett Thomas
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 19, 2025 |
Mar 20, 2025 |
LEVIN ARTHUR A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 18, 2025 |
Mar 20, 2025 |
Kaye Edward M. MD
|
Director |
Sell |
42.5
|
-19,289
|
-12.16%
|
✗
|
$163.7K |
| Mar 18, 2025 |
Mar 20, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
42.5
|
-7,217
|
-10.64%
|
✗
|
$61.2K |
| Mar 18, 2025 |
Mar 20, 2025 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
46.3
|
-4,211
|
-11.77%
|
✗
|
$35.7K |
| Mar 15, 2025 |
Mar 18, 2025 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2025 |
Mar 18, 2025 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2025 |
Mar 18, 2025 |
Kaye Edward M. MD
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 30, 2024 |
Jan 2, 2025 |
Kaye Edward M. MD
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2024 |
Dec 27, 2024 |
Skorpios Trust
|
10% Owner |
Sell |
15.0
|
-2,000,000
|
-22.46%
|
✗
|
$23M |
| Dec 9, 2024 |
Dec 11, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
46.3
|
-2,586
|
-5.46%
|
✗
|
$33.6K |
| Dec 9, 2024 |
Dec 11, 2024 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
10.0
|
-13,666
|
-38.89%
|
✓
|
$186K |
| Dec 9, 2024 |
Dec 11, 2024 |
Kaye Edward M. MD
|
CEO |
Sell |
42.5
|
-6,786
|
-9.88%
|
✗
|
$88.2K |
| Dec 6, 2024 |
Dec 10, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
42.5
|
-13,945
|
-22.76%
|
✗
|
$178.2K |
| Dec 6, 2024 |
Dec 10, 2024 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
42.5
|
-9,696
|
-21.62%
|
✗
|
$123.9K |
| Dec 6, 2024 |
Dec 10, 2024 |
Kaye Edward M. MD
|
CEO |
Sell |
42.5
|
-6,170
|
-8.24%
|
✗
|
$78.8K |
| Dec 3, 2024 |
Dec 10, 2024 |
Kaye Edward M. MD
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 3, 2024 |
Dec 5, 2024 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 3, 2024 |
Dec 5, 2024 |
Kaye Edward M. MD
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 3, 2024 |
Dec 5, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 1, 2024 |
Dec 3, 2024 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 1, 2024 |
Dec 3, 2024 |
Kaye Edward M. MD
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 1, 2024 |
Dec 3, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
20.0
|
-10,000
|
-16.32%
|
✓
|
$120.7K |
| Nov 1, 2024 |
Nov 5, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-10,000
|
-80.10%
|
✓
|
$126.8K |
| Oct 1, 2024 |
Oct 2, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-10,000
|
-80.10%
|
✓
|
$120.6K |
| Sep 19, 2024 |
Sep 23, 2024 |
Skorpios Trust
|
10% Owner |
Sell |
15.0
|
-1,937,500
|
-17.87%
|
✗
|
$27.2M |
| Sep 3, 2024 |
Sep 5, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-10,000
|
-80.10%
|
✓
|
$149.5K |
| Aug 1, 2024 |
Aug 5, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-10,000
|
-80.10%
|
✓
|
$145.8K |
| Jul 2, 2024 |
Jul 3, 2024 |
Nash Huw M.
|
Chief Business Officer |
Sell |
13.8
|
-2,500
|
-100.00%
|
✓
|
$32.8K |
| Jul 1, 2024 |
Jul 3, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-10,000
|
-80.10%
|
✓
|
$137.5K |
| Mar 27, 2024 |
Jun 7, 2024 |
Kaye Edward M. MD
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Jun 7, 2024 |
Nash Huw M.
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Jun 7, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Jun 7, 2024 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Jun 7, 2024 |
Tulipano Stephen J
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Harrison Seth Loring
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Burstein Jennifer
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Smith Julie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
SMITH IAN F
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Menzel Garry E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
TZIANABOS ARTHUR
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
LEVIN ARTHUR A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Krainer Adrian R.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2024 |
Jun 5, 2024 |
Ticho Barry
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-10,000
|
-80.10%
|
✓
|
$152.2K |
| May 20, 2024 |
May 22, 2024 |
Nash Huw M.
|
COO |
Sell |
7.5
|
-50,000
|
-100.00%
|
✓
|
$769.5K |
| May 20, 2024 |
May 22, 2024 |
Kaye Edward M. MD
|
CEO |
Sell |
7.5
|
-42,350
|
-61.07%
|
✓
|
$653.5K |
| May 20, 2024 |
May 22, 2024 |
Allan Jonathan
|
GENERAL COUNSEL & CORP SEC |
Sell |
10.0
|
-8,599
|
-76.80%
|
✓
|
$129.3K |
| May 15, 2024 |
May 17, 2024 |
Leggett Thomas
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 17, 2024 |
Leggett Thomas
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |